Legend Biotech CorporationLEGNNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank12
Year-over-Year Change
Year-over-year operating income growth rate
Percentile
P12
Within normal range
vs 2Y Ago
-1.8x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -98.58% |
| Q2 2025 | 56.80% |
| Q1 2025 | 31.92% |
| Q4 2024 | -6.20% |
| Q3 2024 | -66.90% |
| Q2 2024 | 64.39% |
| Q1 2024 | 1.66% |
| Q4 2023 | -29.54% |
| Q3 2023 | 53.76% |
| Q2 2023 | -61.88% |
| Q1 2023 | 3.87% |
| Q4 2022 | 48.40% |
| Q3 2022 | -108.93% |
| Q2 2022 | 23.20% |
| Q1 2022 | -32.52% |
| Q4 2021 | -35.31% |
| Q3 2021 | 2.30% |
| Q2 2021 | 40.90% |
| Q1 2021 | -153.86% |
| Q4 2020 | 11.17% |
| Q3 2020 | -18.72% |
| Q2 2020 | -23.63% |
| Q1 2020 | 24.95% |
| Q4 2019 | -96.73% |
| Q3 2019 | -5.16% |
| Q2 2019 | -135.56% |
| Q1 2019 | 0.00% |